Literature DB >> 25752457

A novel CD40LG deletion causes the hyper-IgM syndrome with normal CD40L expression in a 6-month-old child.

Gabriela López-Herrera1, José Luis Maravillas-Montero, Alexander Vargas-Hernández, Laura Berrón-Ruíz, Emmanuel Ramírez-Sánchez, Marco Antonio Yamazaki-Nakashimada, Francisco Javier Espinosa-Rosales, Leopoldo Santos-Argumedo.   

Abstract

The X-linked hyper-IgM syndrome (XHIGM) is the most common form of HIGM. Patients are clinically diagnosed on the basis of recurrent sinopulmonary infections, accompanied with low levels of IgG and IgA, normal to elevated levels of IgM, and the presence of peripheral B cells. Here, we have reported a novel deletion of four nucleotides in CD40LG exon 3, c.375_378delCAAA, which led to a frameshift mutation with a premature stop codon, p.Asn101*126. The deletion resulted in a truncated protein, in which majority of the extracellular domain was lost. However, detection of surface CD40L was still possible as the intracellular, transmembrane, and part of the extracellular domains were not affected. This indicated that this mutation did not affect protein stability and that immunodetection of CD40L expression is not enough for the diagnosis of XHIGM. Our study strongly suggests that genetic diagnosis for XHIGM should always be performed when clinical data support this diagnosis and CD40L protein is present.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25752457     DOI: 10.1007/s12026-015-8638-0

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  12 in total

Review 1.  Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.

Authors:  Zhenming Xu; Hong Zan; Egest J Pone; Thach Mai; Paolo Casali
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 2.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

3.  Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives.

Authors:  M L Prasad; M Velickovic; S A Weston; E M Benson
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

4.  Deletions in the ligand for CD40 in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).

Authors:  N Ramesh; R Fuleihan; V Ramesh; S Lederman; M J Yellin; S Sharma; L Chess; F S Rosen; R S Geha
Journal:  Int Immunol       Date:  1993-07       Impact factor: 4.823

5.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

6.  2 A crystal structure of an extracellular fragment of human CD40 ligand.

Authors:  M Karpusas; Y M Hsu; J H Wang; J Thompson; S Lederman; L Chess; D Thomas
Journal:  Structure       Date:  1995-10-15       Impact factor: 5.006

7.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

9.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

Review 10.  Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again.

Authors:  Armin Hirbod-Mobarakeh; Asghar Aghamohammadi; Nima Rezaei
Journal:  Expert Rev Clin Immunol       Date:  2013-11-26       Impact factor: 4.473

View more
  4 in total

1.  X-linked Hyper IgM Syndrome Presenting as Pulmonary Alveolar Proteinosis.

Authors:  Joel Gallagher; Juan Adams; Mary Hintermeyer; Troy R Torgerson; Jesus Lopez-Guisa; Hans D Ochs; Sara Szabo; Mina Salib; James Verbsky; John Routes
Journal:  J Clin Immunol       Date:  2016-06-20       Impact factor: 8.317

2.  X-linked hyper-IgM syndrome complicated with interstitial pneumonia and liver injury: a new mutation locus in the CD40LG gene.

Authors:  Tian-Jiao Wang; Li-Fang Wu; Junguo Chen; Wen Zhu; Hua Wang; Xiao-Lin Liu; Yi-Qun Teng
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

3.  CD40 Ligand Deficiency in Latin America: Clinical, Immunological, and Genetic Characteristics.

Authors:  Tábata Takahashi França; Lucila Akune Barreiros; Ranieri Coelho Salgado; Sarah Maria da Silva Napoleão; Lillian Nunes Gomes; Janáira Fernandes Severo Ferreira; Carolina Prando; Cristina Worm Weber; Regina Sumiko Watanabe Di Gesu; Cecilia Montenegro; Carolina Sanchez Aranda; Gisele Kuntze; Aidé Tamara Staines-Boone; Edna Venegas-Montoya; Juan Carlos Aldave Becerra; Liliana Bezrodnik; Daniela Di Giovanni; Ileana Moreira; Gisela Analia Seminario; Andrea Cecilia Gómez Raccio; Mayra de Barros Dorna; Nelson Augusto Rosário-Filho; Herberto Jose Chong-Neto; Elisa de Carvalho; Milena Baptistella Grotta; Julio Cesar Orellana; Miguel Garcia Dominguez; Oscar Porras; Laura Sasia; Karina Salvucci; Emilio Garip; Luiz Fernando Bacarini Leite; Wilma Carvalho Neves Forte; Fernanda Pinto-Mariz; Ekaterini Goudouris; María Enriqueta Nuñez Nuñez; Magdalena Schelotto; Laura Berrón Ruiz; Diana Inés Liberatore; Hans D Ochs; Otavio Cabral-Marques; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2022-01-04       Impact factor: 8.317

4.  X-linked CD40 ligand deficiency in a 1-year-old male Shih Tzu with secondary Pneumocystis pneumonia.

Authors:  Kristen Merrill; Emily Coffey; Eva Furrow; Isabelle Masseau; Hansjörg Rindt; Carol Reinero
Journal:  J Vet Intern Med       Date:  2020-12-04       Impact factor: 3.175

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.